Pharmgate

What Pharmgate does

Pharmgate Animal Health is a privately held US animal health company founded in 2008 and headquartered in Wilmington, North Carolina. The company manufactures and distributes FDA-approved pharmaceutical products for commercial livestock (swine, cattle, poultry, sheep), spanning four product categories: Type A medicated articles for feed administration (Aivlosin, Pennchlor, Deracin, Pennox, Neo-Oxy, Pennitracin), water-soluble medications for drinking water delivery (Aivlosin WSG, Pennchlor 64, TIA 12.5%), injectable antibiotic solutions (Tulissin 25/100 tulathromycin via Virbac, Tenotryl enrofloxacin via Virbac), and a swine vaccine portfolio (PRRSGard, CircoGard, Circo/MycoGard, MycoGard, MycoGard-1). Proprietary technology includes the PRRSGard modified-live vaccine with chimeric construction using two contemporary PRRS lineage strains and the Circo/MycoGard single-dose 1-mL combination vaccine built on baculovirus expression systems. Operations span four sites: corporate HQ in Wilmington NC, FDA-approved pharmaceutical manufacturing in Omaha NE, vaccine R&D and manufacturing via subsidiary Pharmgate Biologics Inc in St. Paul MN, and Canadian distribution through Pharmgate Animal Health Canada, Inc. in Erin, Ontario. The company maintains a wholly-owned biologics subsidiary (Pharmgate Biologics Inc) and a Canadian subsidiary (Pharmgate Animal Health Canada, Inc.).

The business runs a technically supported, enterprise field-sales go-to-market model. Regional account managers and technical service veterinarians work directly with livestock producers to develop custom herd health protocols, while products flow through prescription (Rx) and Veterinary Feed Directive (VFD) channels via licensed veterinarians. Distribution relies on channel partnerships: Virbac manufactures and supplies Tulissin and Tenotryl injectables through Pharmgate's sales force; Elanco partners on the Pennchlor+Rumensin combination labeling; and ECO Animal Health Group manufactures Aivlosin products for US distribution. The company targets commercial swine producers (primary), cattle producers, and poultry producers, with documented enterprise customers including Smithfield Hog Production, The Maschhooffs LLC, and Iowa Select Farms. Pricing is not publicly disclosed and all products require veterinary authorization under federal VFD law.

Revenue is generated primarily through one-time sale of FDA-approved pharmaceuticals under prescription and VFD frameworks, supplemented by technical-services support. The portfolio emphasizes antibiotics not used in human medicine (notably Aivlosin/tylvalosin), reducing regulatory pressure from medically important antimicrobial stewardship frameworks. Combination approvals (Pennchlor+Rumensin, 2022), label expansions (Aivlosin WSG for reproducing sows, 2023), and ongoing leadership additions (VP of Operations 2023; Director of Technical Veterinary Services 2025) point to a continuing build-out of capability and addressable market rather than a static operating posture.

Name

Pharmgate

Legal name

Pharmgate, LLC

Website

https://pharmgate.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

51–100 employees

Short description

Pharmgate Animal Health is a privately held US animal pharmaceutical company that manufactures and distributes FDA-approved antibiotics, water-soluble medications, injectable solutions, and swine vaccines to commercial swine, cattle, and poultry producers across North America.

Ownership category

akta.pro rank

Product category

Animal Health Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Veterinary Pharmaceutical Wholesalers & Distributors (HLAMAIAA)

akta.pro secondary industries

Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB), Antimicrobials & Anti-infectives (HLAMAEAE), Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK)

Keywords

• Animal health pharmaceuticals
• Livestock medications
• Swine vaccines
• Veterinary antibiotics
• Medicated feed products

Headquarters

HQ city

Wilmington

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Animal Health Pharmaceuticals: Sale of FDA-approved pharmaceutical products including antibiotics, vaccines, and water-soluble medications for livestock (swine, cattle, poultry). Products sold through veterinary prescriptions, VFD (Veterinary Feed Directive), and direct distribution to producers.
2. Technical Services: Technical support and consultation services provided to livestock producers through technical service veterinarians

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Pharmgate Animal Health manufactures and supplies FDA-approved animal pharmaceutical products — antibiotics, water-soluble medications, injectable solutions, and swine vaccines — for the livestock and poultry industries. The company sells these products through veterinary prescription and Veterinary Feed Directive (VFD) channels, supported by a network of regional account managers and technical service veterinarians who deliver on-farm protocol development and herd health support to commercial producers.

Product overview

Pharmgate Animal Health provides a comprehensive portfolio of technically supported animal health products for livestock and poultry, consisting of three main product categories: Type A Medicated Articles (feed medications including Aivlosin, Pennchlor, Deracin, Pennox for antibiotic delivery via feed), Water-soluble Medications (drinking water medications including Aivlosin WSG, Pennchlor 64 for rapid whole-barn treatment), and Injectable Solutions (including Tulissin 25/100, Tenotryl for targeted respiratory disease treatment). The company also offers a swine vaccine portfolio including PRRSGard (PRRS modified-live vaccine), Circo/MycoGard (PCV2 + M. hyo combination vaccine), CircoGard, MycoGard, and MycoGard-1. Products support swine, cattle, poultry, and sheep across antibiotics, water medications, injectables, and vaccines to address respiratory diseases (SRD/BRD), ileitis, bacterial enteritis, pneumonia, and viral threats. Founded in 2008, the company has FDA-approved pharmaceutical production facilities in Omaha, Nebraska and vaccine research and manufacturing in St. Paul, Minnesota.

Differentiator

Problem solved

Functional benefit

Products and services

• Aivlosin (Type A Medicated Article) Macrolide antibiotic (tylvalosin 17%) Type A medicated article administered in feed for control of swine ileitis and respiratory disease. Sold to commercial swine producers through veterinary prescription and VFD channels.
• Aivlosin Water Soluble Granules (WSG) 62.5% w/w tylvalosin (as tylvalosin tartrate) water-soluble granules administered in drinking water for control of porcine proliferative enteropathy (ileitis) and swine respiratory disease (SRD), including reproducing sows. For commercial swine operations.
• Pennchlor Chlortetracycline broad-spectrum antibacterial Type A medicated article administered in feed, available in 50G, 90G, and 100G formulations for swine, cattle, sheep, and poultry. Sold via veterinary prescription and VFD channels.
• Pennchlor 64 Chlortetracycline HCl soluble powder concentrate (64 g/lb) administered in drinking water for treatment of bacterial enteritis and pneumonia in swine, cattle, chickens, and turkeys. For commercial livestock and poultry producers.
• Deracin Chlortetracycline Type A medicated article (generic equivalent to Aureomycin) with broad-spectrum Gram-positive and Gram-negative activity, used for cattle anaplasmosis control. Available in 50, 90, and 100 lb bags.
• Pennox Oxytetracycline-based Type A medicated article administered in feed for livestock production applications.
• Neo-Oxy Type A medicated article combining neomycin and oxytetracycline for livestock health applications.
• Pennitracin MD 50G Type A medicated article for prevention of mortality caused by necrotic enteritis in livestock/poultry.
• TIA 12.5% Water-soluble medication administered in drinking water for livestock.
• Tulissin 25 Tulathromycin 25 mg/mL semi-synthetic macrolide triamilide injectable solution for treatment and control of swine respiratory disease (SRD) and bovine respiratory disease (BRD) in pigs and calves. Distributed via Virbac partnership.
• Tulissin 100 Tulathromycin 100 mg/mL injectable solution for use in larger pigs with five-day pre-slaughter withdrawal time. Distributed via Virbac partnership.
• Tenotryl (Enrofloxacin) Enrofloxacin injectable solution for livestock respiratory disease treatment. Distributed via Virbac partnership with Pharmgate Animal Health.
• PRRSGard Modified-live PRRS (Porcine Reproductive and Respiratory Syndrome) vaccine with chimeric construction using two contemporary lineage strains for reduction of viremia and lung lesions in growing pigs. For commercial swine operations.
• CircoGard PCV2 (Porcine Circovirus Type 2) vaccine for swine.
• Circo/MycoGard Single-dose 1-mL combined PCV2 and Mycoplasma hyopneumoniae vaccine using baculovirus expression systems, clinically proven in challenge studies for pigs.
• MycoGard Mycoplasma hyopneumoniae vaccine for swine.
• MycoGard-1 Mycoplasma hyopneumoniae vaccine variant for swine.

Quantifiable outcome

• Reduced PRRS incidence by more than 90% in affected barns
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered core.

• Elanco Animal HealthcoreStrategic or Co-development Partner · 27 September 2022FDA approved combination use of Pennchlor (chlortetracycline) and Rumensin (monensin) for cattle feeding. Both companies worked collaboratively to make updated labeling and VFD forms available. In 2023, additional supplemental claims were approved for dairy and beef replacement heifers. Rumensin is an Elanco product.
• VirbaccoreChannel Partner/ Reseller/ Distributor · 11 July 2022Virbac launched TENOTRYL (enrofloxacin) injectable solution in the USA with Pharmgate collaboration, further expanding the injectable product portfolio offered through the partnership.
• VirbaccoreChannel Partner/ Reseller/ Distributor · 8 December 2021Virbac announced approval of TULISSIN (tulathromycin injectable) solution in the U.S. with Pharmgate Animal Health collaboration. Virbac produces TULISSIN 25 and TULISSIN 100 injectable solutions, with Pharmgate distributing through their sales channels. This partnership expanded Pharmgate's injectable portfolio for SRD treatment.
• ECO Animal Health GroupcoreOEM/ Whitelabel/ Licensing PartnerECO Animal Health Group manufactures Aivlosin products (62.5% w/w Tylvalosin Water Soluble Granules and Aivlosin 17% Type A Medicated Article) which Pharmgate sells and distributes in the US market. This is a manufacturing and licensing partnership for the Aivlosin product line.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Vetoquinol: Animal health pharma focused on livestock and companion animals, with overlapping antibiotics and feed/water medication offerings for swine, cattle, and poultry producers.
• Virbac: Both a Pharmgate partner (manufactures TULISSIN and TENOTRYL injectables distributed by Pharmgate) and a direct competitor in livestock respiratory antibiotics — supplies US swine and cattle producers directly and via distributors.
• Ceva Santé Animale: Global animal health company with vaccines (e.g., Circovac PRRS variant, Hyogen) and antibiotics overlapping Pharmgate's swine respiratory and PRRS vaccine offerings.
• Phibro Animal Health: Closest peer in scale and product mix — focus on livestock antibiotics (CTC, oxytetracycline), vaccines, and nutritional specialties. Competes head-to-head in feed-grade chlortetracycline and direct-to-producer sales in US pork.
• Huvepharma: Specialty animal-health company with strong livestock antibiotics and coccidiostat portfolios (e.g., Salinomycin, chlortetracycline) targeting similar producer channels as Pharmgate.

Broad incumbents

• Zoetis: Largest pure-play animal health company. Directly competes with Pharmgate in swine respiratory vaccines, macrolide injectables (Draxxin), and chlortetracycline — broad incumbent competing on full-portfolio enterprise contracts.
• Merck Animal Health: Broad incumbent in livestock pharmaceuticals and PRRS/PCV2/M. hyo vaccines (e.g., Ingelvac PRRS MLV, CircoFLEX), directly competing with Pharmgate's swine vaccine portfolio and macrolide injectables.
• Elanco Animal Health: Major animal health incumbent and Pharmgate's partner on the Pennchlor+Rumensin combination. Overlaps in feed/water antibiotics, ionophores, and pork/cattle health solutions across the same producer base.
• Boehringer Ingelheim Animal Health: Major animal-health vaccines and therapeutics incumbent. Its Ingelvac PRRS MLV, MycoFLEX, and CircoFLEX lines are direct competitors to Pharmgate's PRRSGard, MycoGard, and CircoGard vaccines.

Emerging players

• ECO Animal Health Group: Pharmgate's manufacturing and licensing partner for Aivlosin and an emerging competitor in macrolide antibiotics; comparable in scale and product focus, with overlap in global swine respiratory therapeutics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/pharmgate-llc

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharmgate